CN107998250A - 一种复方跌打扭伤药酒及其制备方法 - Google Patents
一种复方跌打扭伤药酒及其制备方法 Download PDFInfo
- Publication number
- CN107998250A CN107998250A CN201711189421.3A CN201711189421A CN107998250A CN 107998250 A CN107998250 A CN 107998250A CN 201711189421 A CN201711189421 A CN 201711189421A CN 107998250 A CN107998250 A CN 107998250A
- Authority
- CN
- China
- Prior art keywords
- parts
- cream powder
- powder
- rhizome
- wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000034656 Contusions Diseases 0.000 title claims abstract description 21
- 208000010040 Sprains and Strains Diseases 0.000 title claims abstract description 21
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims description 9
- 239000000843 powder Substances 0.000 claims abstract description 112
- 239000006071 cream Substances 0.000 claims abstract description 91
- 241001148495 Cibotium barometz Species 0.000 claims abstract description 22
- 241001148782 Davallia Species 0.000 claims abstract description 22
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 22
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 22
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 21
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 21
- 241000244987 Daiswa polyphylla Species 0.000 claims abstract description 21
- 241000123589 Dipsacus Species 0.000 claims abstract description 20
- 241000720991 Illicium Species 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 17
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 16
- 238000000605 extraction Methods 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 12
- 230000032683 aging Effects 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 5
- 239000008236 heating water Substances 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 210000000988 bone and bone Anatomy 0.000 abstract description 11
- 210000003205 muscle Anatomy 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000023597 hemostasis Effects 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 239000000284 extract Substances 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000001151 other effect Effects 0.000 abstract description 4
- 206010020649 Hyperkeratosis Diseases 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 12
- 230000036407 pain Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 244000025254 Cannabis sativa Species 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000006378 damage Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000157511 Oldenlandia Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241000208140 Acer Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- -1 lauro lene Chemical compound 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- HEVGGTGPGPKZHF-UHFFFAOYSA-N 1-(1,2-dimethyl-3-methylidenecyclopentyl)-4-methylbenzene Chemical compound CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- GJRJTYFSORWKBE-UHFFFAOYSA-N Aspidinol Chemical compound CCCC(=O)C1=C(O)C=C(OC)C(C)=C1O GJRJTYFSORWKBE-UHFFFAOYSA-N 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 244000089742 Citrus aurantifolia Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229930003949 flavanone Natural products 0.000 description 2
- 235000011981 flavanones Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000270955 Achnatherum calamagrostis Species 0.000 description 1
- 244000233890 Alisma plantago Species 0.000 description 1
- 235000017300 Alisma plantago Nutrition 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001148787 Davalliaceae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000195958 Dicksoniaceae Species 0.000 description 1
- 241001116742 Drynaria Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033109 Ototoxicity Diseases 0.000 description 1
- 244000020477 Ottelia alismoides Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000195959 Polypodiales Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 240000000920 Typhonium flagelliforme Species 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 241001148769 Woodwardia Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229930189717 aspidinol Natural products 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 210000003477 cochlea Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000009136 dragon's blood Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000262 ototoxicity Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种复方跌打扭伤药酒,属于中药保健药酒技术领域,该复方跌打扭伤药酒,由以下质量份的组分制得:金毛狗脊膏粉20~30份、地枫皮膏粉20~30份、骨碎补膏粉20~30份、续断膏粉15~20份、三七膏粉15~20份、重楼膏粉15~20份、白花蛇舌草膏粉10~15份、桑白皮10~15份、红花10~15份和基酒500~600份;本发明通过将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草、桑白皮、红花等提取物根据中医理论,科学配伍,从整体上调节人体机能,从而达到止血愈伤、活血散瘀、消炎去肿、强筋健骨等功效。
Description
技术领域
本发明涉及一种复方跌打扭伤药酒及其制备方法,属于中药保健药酒技术领域。
背景技术
跌打损伤主要指因跌扑、击打等造成的软组织损伤、外伤肿胀疼痛、皮肉破损出血,也包括摔伤金刃伤等。主要药理为瘀血壅滞、血闭气阻,故以疼痛、肿胀为主要表现。治疗宜补肝肾、强筋骨、活血通络、舒筋行气。现有技术中已有多种治疗跌打损伤的药酒或药水,中华跌打丸、活血止痛胶囊、田三七粉、云南白药正骨水、驳骨水、伤科跌打片、血竭粉胶囊、伸筋胶囊、接骨散治和三七活血膏等,疗效慢。
金毛狗脊为蚌壳蕨科植物金毛狗的根茎。金毛狗脊根茎含淀粉30%左右。狗脊蕨根茎含淀粉高达48.5%,并含鞣质类。根茎含淀粉及绵马酚;根茎的柔毛含鞣质及色素。金毛狗脊植株上金黄色的茸毛,是良好的止血药。伤口流血处,粘上茸毛,立刻就能止住流血。根状茎还有补肝肾、利尿等功效。狗脊属强壮筋骨药,对筋骨不健的病证有治疗和保健的双重作用。主治腰脊强痛,不能俯仰,足膝软弱及风湿腰痛等症。有温补固摄作用,治疗尿频、遗尿,造精,带下等。
地枫皮也叫地风皮、追地风、钻地风,属木兰科。其成分含挥发油0.30%-0.71%,内有:α-和β-蒎烯,樟烯,1,8-桉叶素,芳樟醇,黄樟醚,樟脑,乙酸龙脑酯,月桂烯等28个成。可治疗风湿关节痛;腰肌劳损;蜈蚣咬伤,《新华本草纲要》,树皮:味辛,涩、性温,有小毒。有驱风除湿,行气止痛的功能。
骨碎补,别名:崖姜、岩连姜、爬岩姜、肉碎补、石碎补、飞天鼠、牛飞龙、飞来风、飞蛾草。真蕨目、骨碎补科蕨类植物。其药用功效为:①补肾强骨:能促进骨对钙的吸收,提高血钙和血磷水平,有利于骨钙化和骨盐形成;②抗药毒:本药补水煎剂对卡那霉素和链霉素所致的毒副反应有明显的解毒功效,可减轻卡那霉素对耳蜗的毒性作用,对药物的耳毒性有一定的预防作用,保护肾脏,可减少卡那霉素对肾脏的损害;③降血脂、抗血栓:骨碎补多糖酸盐、甾体内酯和双氢黄酮苷均有降低血清胆固醇的作用。尤以多糖酸盐的作用更为突出;④强心作用:骨碎补双氢黄酮苷有强心作用,能使兔心肌收缩力增加,心律规整,是直接作用于心肌,而非神经***;⑤保肝解毒:骨碎补能激活肝药酶,减轻或解除药物对肝脏的损害,有保肝解毒的作用。⑥补肾,活血,止血:治肾虚久泻及腰痛,风湿痹痛,齿痛,耳鸣,跌打闪挫、骨伤,阑尾炎,斑秃,鸡眼。
续断,原名“还魂丹”,又名和尚头。其性微温,味苦、辛;归肝、肾经。有补肝肾、强筋骨、续折伤、止崩漏的功效,可用于治疗肝肾不足、腰膝酸软、风湿痹痛、筋伤骨折、崩漏、胎漏、跌扑损伤等病症。
三七,别名田七粉,金不换。性温,味甘微苦。富含三七皂苷、三七多糖、三七素、黄酮有效成分,具有止血、活血化瘀、消肿定痛、滋补强壮、抗疲劳、耐缺氧、抗衰老、降血脂、降血压、提高机体免疫功能等作用。
重楼,为百合科植物云南重楼或七叶一枝花的干燥根茎。其味苦,性微寒;有小毒。有清热解毒,消肿止痛,凉肝定惊之功效,常用于疔疮痈肿,咽喉肿痛,蛇虫咬伤,跌扑伤痛,惊风抽搐。
白花蛇舌草,别名:蛇舌草、蛇舌癀、蛇针草、蛇总管、二叶葎、白花十字草、尖刀草、甲猛草、龙舌草、蛇脷草、鹤舌草,为一年生披散草本。其成药味苦、淡,性寒。主要功效是清热解毒、消痛散结、利尿除湿。尤善治疗各种类型炎症。在临床实践中,发现白花蛇舌草若配伍得当,可治疗多种疾病。
桑白皮,桑属落叶灌木或乔木,高3--15m。树皮灰白色。药理作:1.镇静镇痛作用,桑白皮的石油醚、***、乙酸乙酯等脂溶性溶媒的提取物给小鼠静注,能减少小鼠的自发活动,并有抗惊厥的作用;2.抗炎作用,桑白皮水提取物给大鼠口服或注射对角叉菜胶及葡聚糖所引起的脚肿胀有抑制作用;3.抗菌作用,桑白皮煎剂对金黄色葡萄球菌有较强的抑制作用;对伤寒杆菌及福氏痢疾杆菌也有轻度的抑制作用。
红花、别名:红蓝花、刺红花,菊科、红花属植物,干燥的管状花,橙红色,花管狭细,先端5裂,裂片狭线形,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。具有活血通经,去瘀止痛。治经闭,症瘕,难产,死胎,产后恶露不行、瘀血作痛,痈肿,跌扑损伤。
发明内容
针对上述现有技术存在的药品成分复杂,疗效慢问题,本发明提供一种复方跌打扭伤药酒及其制备方法,本发明通过将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草、桑白皮、红花等提取物根据中医理论,科学配伍,从整体上调节人体机能,从而达到止血愈伤、活血散瘀、消炎去肿、强筋健骨等功效。同时本发明所采用的超声波辅助回流浸提技术即不会破坏中药材中有效成分、微量成分以及热敏性成分又能够很好地提高浸提效率并且超声波辅助回流浸提设备成本低、操作简单、适用范围广。
本发明复方跌打扭伤药酒,由以下质量份的组分制得:金毛狗脊膏粉20~30份、地枫皮膏粉20~30份、骨碎补膏粉20~30份、续断膏粉15~20份、三七膏粉15~20份、重楼膏粉15~20份、白花蛇舌草膏粉10~15份、桑白皮10~15份、红花10~15份和基酒500~600份。
所述基酒为酒精度>50%的纯粮食发酵酒或者食用酒精。
本复方跌打扭伤药酒外用或加入到温水中泡脚。
一种复方跌打扭伤药酒的制备方法,具体步骤如下:
(1)制粉:分别将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草、桑白皮、红花粉碎并过筛60目,然后用质量分数为70~80%的食用乙醇分别对各组分-60目粉料进行超声波辅助减压回流浸提,其中各组分粉料与溶液的质量体积比为1g:10~15mL,浸提时间为1~2h,浸提温度55~60℃,浸提结束后用纱布过滤浸提液并取滤液,将滤渣再次浸提、过滤,合并2次滤液并混匀,将混合液再通过离心处理,将离心上清液浓缩,即制备成各组分的膏粉;
(2)混料:将步骤(1)制备得到的金毛狗脊膏粉20~30份、地枫皮膏粉20~30份、骨碎补膏粉20~30份、续断膏粉15~20份、三七膏粉15~20份、重楼膏粉15~20份、白花蛇舌草膏粉10~15份、桑白皮膏粉10~15份、红花膏粉10~15份混均得到混合料;
(3)浸泡:将步骤(2)得到的混合料与质量份为500~600份基酒一起放入密封罐中浸泡15天得到生药酒;
(4)陈酿老熟:将步骤(3)得到的生药酒放入酒缸中密封贮存1个月得到酒体;
(5)将步骤(4)得到的酒体再次通过滤膜过滤得到澄清的酒液,将其灌入瓶中后封口,再水浴加热30min,即可得到成品酒。
本发明的有益效果是:
(1)本发明通过将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草、桑白皮、红花等提取物根据中医理论,科学配伍,从整体上调节人体机能,从而达到止血愈伤、活血散瘀、消炎去肿、强筋健骨等功效。
(2)本发明所采用的超声波辅助回流浸提技术即不会破坏中药材中有效成分、微量成分以及热敏性成分又能够很好地提高浸提效率并且这种超声波辅助回流浸提设备成本低、操作简单、适用范围广。
附图说明
图1是本发明的工艺流程图。
具体实施方式
下面通过附图和实施例对本发明作进一步详细说明,但本发明的保护范围不局限于所述内容。
实施例1
该复方跌打扭伤药酒,由以下质量份的组分制得:金毛狗脊膏粉20g、地枫皮膏粉20g、骨碎补膏粉20g、续断膏粉15g、三七膏粉15g、重楼膏粉15g、白花蛇舌草膏粉10g、桑白皮10g、红花10g和基酒500g。
如图1所示,为该复方跌打扭伤药酒的制备方法工艺流程图,其具体步骤如下:
(1)制粉:分别将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草粉、桑白皮、红花粉碎并过筛60目,再用浓度为70wt%食用乙醇对各组分粉料进行超声波辅助减压回流浸提,其中各组分的粉料与食用乙醇的质量体积比均为1:10g/mL,超声波功率为2000W,浸提时间为1h,浸提温度为55℃,浸提后采用6层纱布过滤,取滤液,将滤渣再次浸提、过滤,合并2次滤液并混匀,将混合液再通过离心处理,将离心上清液真空减压浓缩,即制备成各组分的膏粉(无醇);
(2)混料:将步骤(1)制备得到的金毛狗脊膏粉20g、地枫皮膏粉20g、骨碎补膏粉20g、续断膏粉15g、三七膏粉15g、重楼膏粉15g、白花蛇舌草膏粉10g、桑白皮膏粉10g、红花膏粉10g混均得到混合料;
(3)浸泡:将步骤(2)得到的混合料与500g基酒(酒精度为60%的纯粮食发酵酒)一起放入密封罐中浸泡15天得到生药酒;
(4)陈酿老熟:将步骤(3)得到的生药酒放入酒缸中密封贮存1个月得到酒体;
(5)将步骤(4)得到的酒体再次通过滤膜过滤得到澄清的酒液,将其灌入瓶中后封口,再水浴加热30min即可得到成品酒。
该复方跌打扭伤药酒外用,效果较好。
实施例2
该复方跌打扭伤特效药酒配方,由以下质量份的组分制得:金毛狗脊膏粉30g、地枫皮膏粉30g、骨碎补膏粉30g、续断膏粉20g、三七膏粉20g、重楼膏粉20g、白花蛇舌草膏粉15g、桑白皮15g、红花15g和基酒600g。
如图1所示,为该复方跌打扭伤特效药酒配方的制备方法,其具体步骤如下:
(1)制粉:分别将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草粉、桑白皮、红花粉碎并过筛60目,再用浓度为80wt%食用乙醇对各组分粉料进行超声波辅助减压回流浸提,其中各组分的粉料与食用乙醇的质量体积比均为1:15g/mL,超声波功率为2000W,浸提时间为2h,浸提温度为60℃,浸提后采用6层纱布过滤,取滤液,将滤渣再次浸提、过滤,合并2次滤液并混匀,将混合液再通过离心处理,将离心上清液真空减压浓缩,即制备成各组分的膏粉(无醇);
(2)混料:将步骤(1)制备得到的金毛狗脊膏粉30g、地枫皮膏粉30g、骨碎补膏粉30g、续断膏粉20g、三七膏粉20g、重楼膏粉20g、白花蛇舌草膏粉15g、桑白皮膏粉15g、红花膏粉15g混均得到混合料;
(3)浸泡:将步骤(2)得到的混合料与600g基酒(食用酒精)一起放入密封罐中浸泡15天得到生药酒;
(4)陈酿老熟:将步骤(3)得到的生药酒放入酒缸中密封贮存1个月得到酒体;
(5)将步骤(4)得到的酒体再次通过滤膜过滤得到澄清的酒液,将其灌入瓶中后封口,再水浴加热30min即可得到成品酒。
该复方跌打扭伤药酒加入到温水中泡脚,效果较好。
实施例3
该复方跌打扭伤特效药酒配方,由以下质量份的组分制得:金毛狗脊膏粉25g、地枫皮膏粉25g、骨碎补膏粉25g、续断膏粉17g、三七膏粉17g、重楼膏粉17g、白花蛇舌草膏粉13g、桑白皮膏粉13g、红花膏粉13g和基酒560g。
如图1所示,该复方跌打扭伤特效药酒配方的制备方法,其具体步骤如下:
(1)制粉:分别将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草粉、桑白皮、红花粉碎并过筛60目,再用浓度为75wt%食用乙醇对各组分粉料进行超声波辅助减压回流浸提,其中各组分的粉料与食用乙醇的质量体积比均为1:12g/mL,超声波功率为2000W,浸提时间为1.5h,浸提温度为58℃,浸提后采用6层纱布过滤,取滤液,将滤渣再次浸提、过滤,合并2次滤液并混匀,将混合液再通过离心处理,将离心上清液真空减压浓缩,即制备成各组分的膏粉(无醇);
(2)混料:将步骤(1)制备得到的金毛狗脊膏粉25g、地枫皮膏粉25g、骨碎补膏粉25g、续断膏粉17g、三七膏粉17g、重楼膏粉17g、白花蛇舌草膏粉13g、桑白皮膏粉13g、红花膏粉13g混均得到混合料;
(3)浸泡:将步骤(2)得到的混合料与560g基酒(食用酒精)一起放入密封罐中浸泡15天得到生药酒;
(4)陈酿老熟:将步骤(3)得到的生药酒放入酒缸中密封贮存1个月得到酒体;
(5)将步骤(4)得到的酒体再次通过滤膜过滤得到澄清的酒液,将其灌入瓶中后封口,再水浴加热30min即可得到成品酒。
Claims (4)
1.一种复方跌打扭伤药酒,其特征在于,由以下质量份的组分制得:金毛狗脊膏粉20~30份、地枫皮膏粉20~30份、骨碎补膏粉20~30份、续断膏粉15~20份、三七膏粉15~20份、重楼膏粉15~20份、白花蛇舌草膏粉10~15份、桑白皮10~15份、红花10~15份和基酒500~600份。
2.根据权利要求1所述的复方跌打扭伤药酒,其特征在于:所述基酒为酒精度>50%的纯粮食发酵酒或者食用酒精。
3.根据权利要求1所述的复方跌打扭伤药酒,其特征在于:外用或加入到温水中泡脚。
4.权利要求1或2或3所述的复方跌打扭伤药酒的制备方法,其特征在于具体步骤如下:
(1)制粉:分别将金毛狗脊、地枫皮、骨碎补、续断、三七、重楼、白花蛇舌草、桑白皮、红花粉碎并过筛60目,然后用浓度为70~80wt%的食用乙醇分别对各组分-60目粉料进行超声波辅助减压回流浸提,其中各组分粉料与食用乙醇的质量体积比为1:10~15g/mL,浸提时间为1~2h,浸提温度55~60℃,浸提后,用纱布过滤,取滤液,将滤渣再次浸提、过滤,合并2次滤液并混匀,将混合液再通过离心处理,将离心上清液浓缩,即制备成各组分的膏粉;
(2)混料:将步骤(1)制备得到的金毛狗脊膏粉20~30份、地枫皮膏粉20~30份、骨碎补膏粉20~30份、续断膏粉15~20份、三七膏粉15~20份、重楼膏粉15~20份、白花蛇舌草膏粉10~15份、桑白皮膏粉10~15份、红花膏粉10~15份混均得到混合料;
(3)浸泡:将步骤(2)得到的混合料与质量份为500~600份基酒一起放入密封罐中浸泡15天得到生药酒;
(4)陈酿老熟:将步骤(3)得到的生药酒放入酒缸中密封贮存1个月得到酒体;
(5)将步骤(4)得到的酒体再次通过滤膜过滤得到澄清的酒液,将其灌入瓶中后封口,再水浴加热30min,即可得到成品酒。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711189421.3A CN107998250A (zh) | 2017-11-24 | 2017-11-24 | 一种复方跌打扭伤药酒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711189421.3A CN107998250A (zh) | 2017-11-24 | 2017-11-24 | 一种复方跌打扭伤药酒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107998250A true CN107998250A (zh) | 2018-05-08 |
Family
ID=62053753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711189421.3A Pending CN107998250A (zh) | 2017-11-24 | 2017-11-24 | 一种复方跌打扭伤药酒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107998250A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101669991A (zh) * | 2009-10-10 | 2010-03-17 | 江泽平 | 驳骨酒及其制作方法及用途 |
CN102949500A (zh) * | 2011-08-22 | 2013-03-06 | 天津尖峰弗兰德医药科技发展有限公司 | 一种用于脚扭伤的外用中药制剂及制备方法 |
CN103877157A (zh) * | 2014-04-21 | 2014-06-25 | 张超 | 一种接骨中药及其制作方法 |
-
2017
- 2017-11-24 CN CN201711189421.3A patent/CN107998250A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101669991A (zh) * | 2009-10-10 | 2010-03-17 | 江泽平 | 驳骨酒及其制作方法及用途 |
CN102949500A (zh) * | 2011-08-22 | 2013-03-06 | 天津尖峰弗兰德医药科技发展有限公司 | 一种用于脚扭伤的外用中药制剂及制备方法 |
CN103877157A (zh) * | 2014-04-21 | 2014-06-25 | 张超 | 一种接骨中药及其制作方法 |
Non-Patent Citations (1)
Title |
---|
陶德林: "正交法优选复方骨碎补接骨片提取工艺的研究", 《中国现代应用药学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105496917A (zh) | 一种积雪草抗皱面霜及其制备方法 | |
CN106668274A (zh) | 具有美容、止痛止痒的外用中药保健制剂及其制备方法 | |
KR20070112935A (ko) | 생약조성물과 그 제조방법 | |
CN104127813A (zh) | 一种治疗气血两虚型褥疮的中药组合物及其制备方法 | |
CN103933509A (zh) | 用于治疗淡水鱼水霉病的药物及其制备方法 | |
CN105288597A (zh) | 一种治疗皮肤色素沉着的药物 | |
CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
CN105194264A (zh) | 一种治疗便秘的中药冲剂及其制备方法 | |
KR101080458B1 (ko) | 당귀 추출물이 포함된 액상차 및 그 제조방법 | |
CN107998250A (zh) | 一种复方跌打扭伤药酒及其制备方法 | |
CN108042686A (zh) | 一种复方跌打扭伤膏药及其制备方法 | |
CN107648428A (zh) | 一种复方跌打扭伤特效药酒配方、制备方法及其应用 | |
KR102598936B1 (ko) | 관능 효과가 개선된 골절 회복을 촉진하는 조성물의 제조방법 | |
CN110522798A (zh) | 一种主治冠心病的复方制剂及其制备方法 | |
CN108938794A (zh) | 一种驱风止痛的外用剂及其制备方法 | |
CN107582803A (zh) | 一种复方跌打扭伤特效膏药配方、制备方法及其应用 | |
CN105998979A (zh) | 一种治疗肺肾阴虚型慢性咽炎的中药组合物及方法 | |
CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 | |
CN101574427B (zh) | 辅助戒毒的中药组合物和含有该组合物的中药 | |
CN107550983A (zh) | 一种跌打扭伤特效膏药配方、制备方法及其应用 | |
CN105963533A (zh) | 治疗慢性咽炎的中药制备方法及其含片 | |
CN105125746B (zh) | 一种治疗便秘的中成药及其汤剂的制备方法 | |
CN104771601A (zh) | 一种改善血粘度和血小板的聚集的组合剂 | |
CN103948813A (zh) | 一种用于治疗猫胃肠炎的中药组合物及其制备方法 | |
CN107638439A (zh) | 一种跌打扭伤药酒及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180508 |
|
RJ01 | Rejection of invention patent application after publication |